Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
135.38
+0.58 (+0.43%)
Streaming Delayed Price
Updated: 10:34 AM EDT, May 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
44
45
Next >
Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits
July 08, 2024
Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial among hundreds of similar lawsuits, impacting Abbott and Reckitt...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
The 3 Best Healthcare Stocks to Buy in July 2024
July 04, 2024
Consistent breakthroughs, improved products and relatively consistent growth make these the best healthcare stocks to buy.
Via
InvestorPlace
AbbVie Stock: A Perfect Dip for Investors to Buy
July 03, 2024
ABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investors
Via
MarketBeat
Topics
ETFs
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven
July 02, 2024
These Dividend Aristocrats all have payouts yielding three times or more the average yield of the S&P 500.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
7 Analysts Have This To Say About Abbott Laboratories
July 02, 2024
Via
Benzinga
Market Whales and Their Recent Bets on ABT Options
June 27, 2024
Via
Benzinga
Abbott Laboratories's Options: A Look at What the Big Money is Thinking
June 10, 2024
Via
Benzinga
3 MedTech Stocks to Buy for Healthy Gains
July 01, 2024
With innovations in healthcare moving at a rapid clip, investors should consider these enticing MedTech stocks to buy.
Via
InvestorPlace
Stocks Going Ex Dividend In July 2024
June 27, 2024
This article features a short list of some of the many stocks going ex-dividend during the next month, which can be helpful for traders and investors interested in the stock trading technique known as...
Via
Talk Markets
Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income
June 24, 2024
Buying dividend stocks for income is a smart investment strategy to juice your portfolio's returns even in down markets.
Via
InvestorPlace
Top Analyst Reports For Abbott, BP & Gilead
June 21, 2024
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories, BP p.l.c.and Gilead Sciences, Inc., as well as two micro-cap stocks Smith-Midland Corp. and...
Via
Talk Markets
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year
June 20, 2024
The power of compounding can build huge amounts of passive income.
Via
The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
June 20, 2024
These healthcare players offer you dividends and a strong earnings picture.
Via
The Motley Fool
2 Healthcare Stocks to Buy Hand Over Fist in June
June 12, 2024
They both have pretty impressive pasts, and their prospects look just as bright.
Via
The Motley Fool
2 Magnificent Dividend Growth Stocks to Buy Now
June 11, 2024
These two dividend growth stocks are potent capital appreciation vehicles.
Via
The Motley Fool
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
June 10, 2024
The FDA clearance for two new CGMs puts Abbott on track to rival Dexcom's new Stelo device.
Via
Investor's Business Daily
Exposures
Product Safety
Class Action Against Abbott's Glucerna Products Proceeds in Federal Court
June 07, 2024
WuXi AppTec employees collaborated with China's PLA on altitude sickness drugs, raising national security concerns in the U.S. Congressional committee calls for restricting biotech ties amid ongoing...
Via
Benzinga
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
June 07, 2024
Dividend stocks have a record of stability and growth. Read here about three picks that are thriving and hiking dividends amid uncertainty.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
June 04, 2024
Via
Benzinga
Berkshire Hathaway, Chipotle, More NYSE Stocks Hit With Trading Halts Triggered By Technical Issues
June 03, 2024
NYSE experiences trading halts Monday due to a technical issue. Stocks like Berkshire Hathaway and Chipotle are impacted.
Via
Benzinga
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
May 30, 2024
Vertex might not present a clear and present danger to Abbott and DexCom but could present a clear future threat.
Via
The Motley Fool
The 3 Best MedTech Stocks to Buy Now: May 2024
May 29, 2024
Explore the best MedTech stocks to buy now that are driven by AI's potential to revolutionize healthcare efficiency.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for May 2024
May 28, 2024
Investors would be wise to pay attention to the analyst ratings on these leading healthcare stocks to buy, which are expected to rise.
Via
InvestorPlace
Reliable Rewards: 7 Dividend Stocks to Count On in Any Market
May 27, 2024
With uncertainty clouding the market, investors can sleep a little easier at night with these reliable dividend stocks.
Via
InvestorPlace
Blue-Chip Bonanza: 3 Stocks to Ride the Market’s Coattails to Riches
May 27, 2024
The bull market momentum is unstoppable and these blue-chip stocks have the earnings growth to drive upside.
Via
InvestorPlace
8 Health Care Stocks Whale Activity In Today's Session
May 23, 2024
Via
Benzinga
Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know
May 22, 2024
Via
Benzinga
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
May 21, 2024
EQNX::TICKER_START (OTCPK:MUSLF),(CSE:MUSL),(NYSE:ABT),(NASDAQ:CELH),(NASDAQ:MNST),(NYSE:BRBR) EQNX::TICKER_END
Via
FinancialNewsMedia
Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose
May 21, 2024
Cramer recommends staying away from Canada Goose, even though it reported better-than-expected Q4 earnings.
Via
Benzinga
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
May 21, 2024
From
FN Media Group LLC
Via
GlobeNewswire
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
44
45
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.